Email has been sent to with instructions on resetting your password.
Enroll in a Dignity Health account to simplify finding a doctor and scheduling an appointment. Let's start!
By selecting "I Agree" or "Create Account" and clicking the box "I AGREE" below, you acknowledge and agree that you have read, understood and accepted the terms of service at the hyperlink below:
Legal and Privacy Notices
Press Center and News
Awards & Recognition
St. Joseph's Executive Leadership
History of St. Joseph's
St. Joseph's Mission, Vision and Values
Research and Education
Sponsorship Request Application
“As physicians, our number one goal is to provide our patients with the best possible care available. On average 20 percent of our patients have participated in a cancer clinical trial,” said Dr. Bradley Monk, director of the Division of Gynecological Oncology at St. Joseph. “The real story of this award is the difference we are making in patients’ lives by offering these groundbreaking trials.” Their studies include investigating ways to stimulate the immune system to fight cancerous tumors, developing medications that choke off the blood vessels feeding cancers, as well as using new innovative chemotherapies.
Practices were selected to receive the award based on several different criteria, which emphasize high patient growth in clinical trials by overcoming barriers to enrollment. As of 2014, 50 trials were available to women with cancer at St. Joseph’s and more than 150 patients have been enrolled. Ongoing trials continue to further this commitment to high-quality research in gynecological cancer. Preference was also given to practices with clinical trials programs that serve and connect with underrepresented populations in their communities.
“The Conquer Cancer Foundation of the American Society of Clinical Oncology is pleased to recognize the Division of Gynecologic Oncology at St. Joseph’s Hospital and Medical Center in Phoenix with the Clinical Trials Participation Award for providing local patients with access to high-quality clinical research that will help achieve groundbreaking advancements in cancer care,” said Dr. W. Charles Penley, chair of the Conquer Cancer Foundation Board of Directors.
2-2-2-2 For Excellence in Clinical Trials In Cancer Research 2-2-2-2
The Clinical Trials Participation Award is funded through the Conquer Cancer Foundation of ASCO with the generous support of the Coalition of Cancer Cooperative Groups, which has supported the award since it was established in 2003.
For more information regarding clinical trial participation at St. Joseph’s, please call 1.800.227.7691.
The Conquer Cancer Foundation (CCF) was created by the world’s foremost cancer doctors of the American Society of Clinical Oncology to seek dramatic advances in the prevention, treatment and cures of all types of cancer. Toward the vision of a world free from the fear of cancer, CCF works to conquer this disease by funding breakthrough cancer research and sharing cutting-edge knowledge with patients and physicians worldwide, and by improving quality of care and access to care, enhancing the lives of all who are touched by cancer. For more information, visit www.conquercancerfoundation.org.